| Patent application number | Description | Published |
|---|
| 20090043667 | System And Method For Real Time Account and Account Number Generation Using Origination APIS - A system and method generate an account in real time in accordance with an application programming interface (API). The API contains parameter descriptions listing universal resource locator (URL) parameters associated with items. A format for implementing an http request to transmit data to in compliance with the defined format is disclosed. A transparent mode for transmitting a response to an http request transmitting data provides for the transmission of an extensible markup language (XML) formatted file communicating an outcome to the request. | 02-12-2009 |
| 20090043677 | SYSTEM AND METHOD FOR REAL TIME ACCOUNT AND ACCOUNT NUMBER GENERATION USING ORIGINATION APIS - A system and method generate an account in real time in accordance with an application programming interface (API). The API contains parameter descriptions listing universal resource locator (URL) parameters associated with items. A format for implementing an http request to transmit data to in compliance with the defined format is disclosed. A transparent mode for transmitting a response to an http request transmitting data provides for the transmission of an extensible markup language (XML) formatted file communicating an outcome to the request. | 02-12-2009 |
| 20110093382 | SYSTEM AND METHOD FOR FUNDING A PREPAID CARD ACCOUNT WITH A LOAN - Systems and methods for funding a prepaid card account with a loan are disclosed. One embodiment includes, receiving, by an account manager at a host server, a request from a customer to fund the prepaid card account through obtaining a loan from a lender, comparing user data of the customer to a set of metrics to determine whether the customer meets qualifications for funding the prepaid card account through the loan, comparing user data of the customer to a set of metrics to determine whether the customer meets qualifications for funding the prepaid card account through the loan, presenting the terms of the loan to the user via the user device, and/or funding, by the account manager, the prepaid card account using the loan, responsive to the customer accepting the terms of the loan. | 04-21-2011 |
| Patent application number | Description | Published |
|---|
| 20100135994 | HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS - The present invention includes compositions and methods for making and using a vaccine that includes a DC-specific antibody or fragment thereof to which an engineered Gag antigen is attached to form an antibody-antigen complex, wherein the Gag antigen is less susceptible to proteolytic degradation by eliminating one or more proteolytic sites or a DC-specific antibody or fragment thereof to which an engineered Nef antigen is attached to form an antibody-antigen complex, wherein the Nef antigen comprises one or more codon usage optimization that increase antibody-antigen complex secretion, or both, wherein the vaccine is able to elicit an HIV-specific T cell immune response to Gag p17, Gag p24, Nef and/or Cyclin D1. | 06-03-2010 |
| 20100291082 | ANTIGEN PRESENTING CELL TARGETED ANTI-VIRAL VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 11-18-2010 |
| 20100297114 | ANTIGEN PRESENTING CELL TARGETED VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 11-25-2010 |
| 20100322929 | ANTIGEN PRESENTING CELL TARGETED CANCER VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 12-23-2010 |
